Navigation For Mobile

Author Archives: Saharsh Davuluri

Big Pharma Keeps Getting Bigger…by Shrinking?

An article at Pharma Manufacturing (Shrinking Big Pharma) pointed to the recent movement among Big Pharma towards smaller production floors. It comes as no surprise. With the rise of target-based…

Posted in generic, Uncategorized | Tagged , , | Comments Off on Big Pharma Keeps Getting Bigger…by Shrinking?

Case Studies from Neuland’s Process Engineering Lab

In our PE Lab, a team of 27 highly specialized engineers integrates the key attributes of QbD process understanding, process control, and continuous improvement with advanced equipment, Design of Experiments…

Posted in analytical science, API synthesis, APIs, Capabilities, Chemistry, Design of Experiment, method development, micronization, Neuland Labs, PAT, process chemistry, Process Engineering, QbD, Quality, Route Scouting, Synthesis Route | Comments Off on Case Studies from Neuland’s Process Engineering Lab

Ringing Hyderabad: Neuland’s Home in Genome Valley

With the recent acquisition of Unit III, Neuland’s footprint around Hyderabad continues to grow. Hyderabad, for those not familiar with India’s fourth most populous city, is a hive of finance,…

Posted in Hyderabad, Neuland Labs | Comments Off on Ringing Hyderabad: Neuland’s Home in Genome Valley

Emerging Peptide Technology Spotlight: Molecular Hiving

Earlier this year, Neuland began working with a technology called Molecular HivingTM along with Jitsubo Co. (Read the March 2018 press release here).  It’s a patented technique to manufacture peptides…

Posted in Chemistry, Jitsubo, Molecular Hiving, peptide, peptides, Process Engineering | Comments Off on Emerging Peptide Technology Spotlight: Molecular Hiving

Generic Drugs: Despite Dominance, Consumer Perception Issues Linger

Generics: U.S. Drug Industry Dominance The last time you filled a prescription, was it a generic or a brand name drug? An astonishing 89% of all drug prescriptions in the…

Posted in APIs, drugs, generic, Neuland Labs, Quality, regulatory, supply chain | Comments Off on Generic Drugs: Despite Dominance, Consumer Perception Issues Linger

Neuland Patent Spotlight: Entacapone & Parkinson’s Disease

Treating the Symptoms of Parkinson’s Disease According to the Parkinson’s Foundation, Parkinson’s Disease (PD) affects about one million people in the U.S., and 10 million worldwide. While there is no…

Posted in APIs, drugs, Neuland Labs, Parkinson's | Comments Off on Neuland Patent Spotlight: Entacapone & Parkinson’s Disease

API Synthesis Properties Affecting Yield, Delivery Date & Purity

Properties which can affect an API’s yield, delivery date and purity include: Type of Synthesis Propinquity Complexity of Structure Cost Efficient Synthesis Carryover of impurities into drug substance Minimum isolation…

Posted in API synthesis, APIs, Chemistry, CMC, method development, Neuland Labs, process chemistry, Process Engineering, Route Design, Route Scouting, synthesis, Synthesis Route | Comments Off on API Synthesis Properties Affecting Yield, Delivery Date & Purity

Overcoming Challenges in Complex Peptide Purification

Growth in Peptide Demand In its most recent market report, Grandview Research estimated the peptide therapeutics market will reach nearly $50 billion. Of particular interest is what is driving the…

Posted in Uncategorized | Comments Off on Overcoming Challenges in Complex Peptide Purification

Neuland & Generic Drug Substances (GDS)

From the day Neuland was established in 1984, our core business and operational expertise has been the manufacturing of Generic Drug Substances. More specifically, delivering niche, highly-specialized and complex synthetic…

Posted in API synthesis, APIs, Chemistry, Contract Manufacturing, drugs, generic, method development | Comments Off on Neuland & Generic Drug Substances (GDS)

Pharmaceutical Manufacturing: Comparing Particle Reduction Techniques

While there are a number of particle size reduction technologies in use in the pharmaceutical industry today, from our vantage point as an API manufacturer we typically see requests for…

Posted in APIs, Chemistry, micronization, particle size, Process Engineering | Comments Off on Pharmaceutical Manufacturing: Comparing Particle Reduction Techniques